Company: INDP
Filing Date: 2025-06-13
Form Type: 8-K
Source: 0001641172-25-014972
Chunk: 3

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-13
Form: 8-K
Item: Item 3.02
Chunk 3
---
Item       Unregistered                 

The
information contained above in Item 1.01 relating to the Notes, Warrants, Warrant Shares, Placement Agent Warrants and the shares
of common stock issuable upon the exercise of the Placement Agent Warrants are incorporated by reference into this Item 3.02
in its entirety. Based in part upon the representations of the Purchasers in the Purchase Agreements and Paulson in the PAA, the offering
and sale of the Notes, Pre-Funded Warrants, Warrants and Placement Agent Warrants will be exempt from registration under Section
4(a)(2) of the Securities Act of 1933, as amended (the “ Securities Act”), and/or Rule 506(c) of Regulation D promulgated
under the Securities Act. The issuances and sales of the Notes, Pre-Funded Warrants, Warrants, Placement Agent Warrants
and the shares of Common Stock underlying each of the foregoing will not be registered under the Securities Act or any state securities
laws, and such securities may not be offered or sold in the United States absent registration with the Securities and Exchange Commission
or an applicable exemption from the registration requirements.

The
Company may continue offering additional Notes and Warrants on the same terms until the Company has raised a maximum of $5 million in
gross proceeds (unless increased at the discretion of the Company).